PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

TRAVERE THERAPEUTICS

CA · US

Biopharmaceuticals

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$2,016,000

Connections

3

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$3.6M
PHAPharmacy
$3.6M
MEDMedical/Disease Research
$3.6M
MMMMedicare/Medicaid
$3.6M
TAXTaxation/Internal Revenue Code
$3.3M
CPTCopyright/Patent/Trademark
$2.2M

Lobbying Firms Retained

TRAVERE THERAPEUTICS$2.2M
ALSTON & BIRD LLP$960K
THE HEALTH EQUITY STRATEGIES GROUP, LLC$271K
2359 STRATEGIES$150K

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Employed byALSTON & BIRD LLPHired ALSTON & BIRD LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed by2359 STRATEGIESHired 2359 STRATEGIES to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byTHE HEALTH EQUITY STRATEGIES GROUP, LLCHired THE HEALTH EQUITY STRATEGIES GROUP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source